by kkluglein | Nov 21, 2020 | Blog, Tips & Expertise
Q: When is code I12.9 used? I thought that was for hypertension with CKD without CHF? A: Code I12.9 is for hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease. This code is used when the...
by kkluglein | Oct 27, 2020 | Blog, Covid News
If you’ve been keeping up to date on your Coding Clinic subscription and coding guidelines, you know that coding advice for COVID-19 keeps changing. As coders, we know it’s imperative to keep our eyes peeled for new codes, updated guidance, and evolving disease...
by Kristi Pollard | Oct 27, 2020 | Blog
November is American Diabetes Month and there’s no better time to review one of the most common coding variances we see on coding audits: coding for diabetic complications. Later this month, I will present a webinar on this topic, but for now, let’s get a jump on it...
by kkluglein | Oct 15, 2020 | Blog, Tips & Expertise
Q: Question about fatty liver disease. It’s my understanding that fatty liver disease is often the first stage in liver disease and can progress to cirrhosis. If the provider documents fatty liver disease as well as cirrhosis, should you code both or is the...
by kkluglein | Oct 2, 2020 | Blog, Tips & Expertise
Q: You mentioned that Yescarta and Kymriah would group to the new MS-DRG 018 for CAR T-cell therapies. There are 2 new codes for CAR T-cell therapies from the new technology section in 2021. Will those codes also group to MS-DRG 018? A: Two new CAR T-cell...
by Jennifer Cayce | Sep 2, 2020 | Blog
Are you looking for opportunities for focused audit reviews or coder education? At HCG, we track our audit data throughout the year to identify trends in the industry and opportunities to educate coders in specific problem areas. So far, in 2020, we have identified 4...
